Indeed, gemcitabine enhanced WT1 expression in human pancreatic cancer cells and sensitized the pancreatic cancer cells with WT1-specific T cell-mediated antitumor responses [131]. This evidence concerns the gene WT1 and familial pancreatic carcinoma.